GeoVax Labs Inc. Common Stock (GOVX)
Stock · NASDAQ · Health Care
$0.721as of 8/28/2026
Price chart
Open in TradingViewActive signals
About GOVX
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phas…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 19
- Website
- www.geovax.com/
Fundamentals
- 1-day range
- $0.68$0.7274
- Market cap
- $5.34M
- P/E (trailing)
- —
- P/E (forward)
- -0.84
- EPS (trailing)
- $-13.92
- Dividend yield
- —
- Beta
- 3.74
- Avg. volume
- 742.1K
- Dividend pay date
- September 25, 2020
How GeoVax Labs Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Apr 15, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
GeoVax Labs Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GOVXGeoVax Labs Inc. Common Stock$0.7195▲ 0.35%Market cap $5.34MP/E —$0.59$19.2
- BGMSBio Green Med Solution Inc. Common Stock$0.86▼ 3.37%Market cap $5.35MP/E 0.18$0.5664$8.82
- LABTLakewood-Amedex Biotherapeutics Inc. Common Stock$2.3▼ 4.56%Market cap $5.12MP/E —$0.366$9.82
- ERNAErnexa Therapeutics Inc. Common Stock$4.57▼ 4.99%Market cap $5.09MP/E —$3.18$71.5
- NCNANuCana plc American Depositary Share$1.79▲ 21.43%Market cap $5.62MP/E 0.01$1.21$7.22
- JUNSJupiter Neurosciences Inc. Common Stock$4.59▼ 6.13%Market cap $5.65MP/E —$4.1$138
- APVOAptevo Therapeutics Inc. Common Stock$2.36▼ 2.48%Market cap $4.92MP/E 0.00$2.3$48.78
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GOVX GeoVax Labs Inc. Common Stock | $5.34M | — | $0.7195 | ▲ 0.35% | $0.59$19.2 |
| BGMS Bio Green Med Solution Inc. Common Stock | $5.35M | 0.18 | $0.86 | ▼ 3.37% | $0.5664$8.82 |
| LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock | $5.12M | — | $2.3 | ▼ 4.56% | $0.366$9.82 |
| ERNA Ernexa Therapeutics Inc. Common Stock | $5.09M | — | $4.57 | ▼ 4.99% | $3.18$71.5 |
| NCNA NuCana plc American Depositary Share | $5.62M | 0.01 | $1.79 | ▲ 21.43% | $1.21$7.22 |
| JUNS Jupiter Neurosciences Inc. Common Stock | $5.65M | — | $4.59 | ▼ 6.13% | $4.1$138 |
| APVO Aptevo Therapeutics Inc. Common Stock | $4.92M | 0.00 | $2.36 | ▼ 2.48% | $2.3$48.78 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Wondering what's happening in today's after-hours session?ChartMill · 8/28/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 8/28/2026
- World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic EmergencyBenzinga · 8/28/2026
- The trading volume of these stocks is deviating from the norm in today's session.ChartMill · 8/24/2026
Insider Activity
Insider Actions →- Morgan Jayne · June 17, 2026 · Grant6.0K
- Lemerond Nicole · June 17, 2026 · Grant6.0K
- McKee Kelly T. Jr. · June 17, 2026 · Grant17.6K
- Sharkey John W. · June 17, 2026 · Grant17.6K
- Kollintzas Dean G · June 17, 2026 · Grant6.0K
- Reynolds Mark · June 17, 2026 · Grant17.6K
- SPENCER JOHN N JR · June 17, 2026 · Grant6.0K
- NEWMAN MARK J · June 17, 2026 · Grant17.6K
- DODD DAVID A · June 17, 2026 · Grant29.3K
- CHASE RANDAL D · June 17, 2026 · Grant6.0K
- MCNALLY ROBERT T · June 17, 2026 · Grant6.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 328.3K
- Total value held
- $438.6K
- Institutional holders
- 15
- Unknown269.3K
- Unknown36.1K
- Unknown10.5K
- Unknown4.2K
- Unknown3.5K
- Unknown3.2K
- Unknown1.1K
- Unknown384
- Unknown31
- Unknown6
See the full, filterable feed with live charts on the MarketWall dashboard.